Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$0.37 - $1.69 $72 - $329
-195 Reduced 3.22%
5,865 $4,000
Q2 2023

Jul 24, 2023

SELL
$0.39 - $1.69 $435 - $1,887
-1,117 Reduced 15.56%
6,060 $2,000
Q1 2023

May 30, 2023

BUY
$1.75 - $3.14 $229 - $411
131 Added 1.86%
7,177 $12,000
Q1 2023

May 03, 2023

BUY
$1.75 - $3.14 $229 - $411
131 Added 1.86%
7,177 $12,000
Q4 2022

May 30, 2023

SELL
$2.09 - $4.32 $273 - $565
-131 Reduced 1.83%
7,046 $16,000
Q4 2022

Feb 14, 2023

SELL
$2.09 - $4.32 $156 - $324
-75 Reduced 1.05%
7,046 $16,000
Q2 2022

Aug 01, 2022

SELL
$2.85 - $7.77 $2,032 - $5,540
-713 Reduced 9.1%
7,121 $20,000
Q1 2022

May 10, 2022

BUY
$5.7 - $9.3 $153 - $251
27 Added 0.35%
7,834 $59,000
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $7,193 - $12,582
824 Added 11.8%
7,807 $68,000
Q3 2021

Nov 15, 2021

BUY
$13.52 - $23.95 $94,410 - $167,242
6,983 New
6,983 $97,000
Q1 2021

May 26, 2021

SELL
$26.12 - $52.17 $128,902 - $257,458
-4,935 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.05 - $29.0 $1,489 - $3,074
106 Added 2.2%
4,935 $122,000
Q3 2020

Nov 13, 2020

BUY
$14.17 - $19.48 $68,426 - $94,068
4,829 New
4,829 $69,000
Q1 2020

May 14, 2020

SELL
$9.73 - $24.9 $39,912 - $102,139
-4,102 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$14.22 - $23.38 $6,000 - $9,866
422 Added 11.47%
4,102 $87,000
Q3 2019

Nov 12, 2019

BUY
$22.93 - $41.06 $1,008 - $1,806
44 Added 1.21%
3,680 $84,000
Q2 2019

Aug 13, 2019

BUY
$38.73 - $52.03 $12,742 - $17,117
329 Added 9.95%
3,636 $147,000
Q1 2019

May 13, 2019

BUY
$28.11 - $50.77 $34,828 - $62,904
1,239 Added 59.91%
3,307 $143,000
Q4 2018

Feb 25, 2019

BUY
$26.22 - $56.89 $48,795 - $105,872
1,861 Added 899.03%
2,068 $56,000
Q4 2018

Feb 14, 2019

BUY
$26.22 - $56.89 $5,427 - $11,776
207 New
207 $56,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $2.2B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.